Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q3 FY23 results · Oct–Dec 2022

Insecticides (India) reported revenue from operations of ₹356.53 crore (up 13.6% from Q3 FY22) and net profit of ₹9.37 crore (up 13.5% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations356.53313.78+13.6%582.21−38.8%
Other income0.370.87−56.9%0.28+31.8%
Total income356.91314.65+13.4%582.49−38.7%
Profit before share of associates & JVs and tax12.3610.94+13.0%59.60−79.3%
Share of profit/(loss) of associates & JVs0.090.100.17
Net profit for the period9.378.26+13.5%44.83−79.1%
EPS, basic (₹)3.164.18not comparable15.15not comparable
Net margin (%)2.62.67.7

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations356.53313.78+13.6%582.21−38.8%
Other income0.370.87−56.9%0.28+31.8%
Total income356.91314.65+13.4%582.49−38.7%
Profit before tax12.4210.94+13.5%59.60−79.2%
Net profit for the period9.338.15+14.5%44.67−79.1%
EPS, basic (₹)3.154.13not comparable15.09not comparable
Net margin (%)2.62.67.7
Consolidated
Filed with BSE
16 Feb 2023, 15:11 IST
Board meeting
13 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
16 Feb 2023, 15:11 IST
Board meeting
13 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE